Tagrix Tablets

Tagrix Tablets

Product Details:

  • Drug Type Other Types
  • Ingredients Osimertinib
  • Physical Form Tablets
  • Function Anti-Cancer
  • Dosage 80 mg
  • Quantity 10 Boxes
  • Supply Ability : 1000 Pack Per Day
1 USD ($)/Unit
X

Price And Quantity

  • 1 USD ($)/Unit
  • 10 Pack

Product Specifications

  • Anti-Cancer
  • Other Types
  • Osimertinib
  • 10 Boxes
  • Tablets
  • 80 mg

Trade Information

  • mumbai
  • 1000 Pack Per Day
  • 10 Days
  • Contact us for information regarding our sample policy

Product Description

Specification

Brand

Tagrix

Packaging Type

Packet

Usage/Application

Cancer

Anti Cancer Medicine Type

Non-small cell Lung Cancer

Composition

Osimertinib 80mg

Drug Name

Osimertinib 80mg

Packaging Size

30 Tabs

Dose Strength

80mg

Category

Lung Cancer

Drug

Osimertinib 80mg

Generic Name

Osimertinib 80mg

Form Of Medicines

Tablets

Type

Allopathic

Dose/Strength

80mg

Dosage Form

Tablet

Form Of Medicine

API

Shelf Life

24 months

Product Type

Finished Product

Type Of Medicines

Allopathic

Grade Standard

Medicine Grade

AsparĀ® Pharmaceuticals is a leading manufacturer and exporter of Tagrix Tablet ( Osimertinib 80mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

 

Indication: Tagrix Tablet (Osimertinib 80mg) Tagrix Tablet is used to treatment of Non-small cell Lung Cancer. 

 

Uses:- Tagrix Tablet (Osimertinib 80mg) Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.

 

How it works:- Tagrix Tablet (Osimertinib 80mg) Tagrix Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

 

Available other Brand : Tagrisso.


ASPAR PHARMACEUTICALS

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



ASPAR PHARMACEUTICALS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.